Enhanced Gastric and Duodenal Platelet-Activating Factor and Leukotriene Generation in Duodenal Ulcer Patients

References

• Braquet P, Touqui L, Shen T Y, Vargaftig B B. Perspectives in platelet activating factor research. Pharmacol Rev 1987; 39: 97–145
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–575
   PubMed Web of Science ®Google Scholar
• Rosam A C, Wallace J L, Whittle B JR. Potent ulcerogenic actions of platelet activating factor on the stomach. Nature 1986; 319: 54–56
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Profile of gastrointestinal damage by platelet activating factor. Prostaglandins 1986; 32: 137–141
   PubMedGoogle Scholar
• Konturek S J, Brzozowski T, Drozdowicz D, Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol. taurocholatc, aspirin platelet-activating factor and stress in rats. Dig Dis Sci 1988; 33: 806–813
   PubMed Web of Science ®Google Scholar
• Gonzalez-Crussi F, Hsueh W. Experimental model of ischemic bowel necrosis: the role of platelet activating factor and endotoxin. Am J Pathol 1983; 112: 127–135
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Prevention of endotoxin induced gastrointestinal damage by CV-3988. an antagonist of platelet activating factor. Eur J Pharmacol 1986; 124: 209–210
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 1986; 31: 989–998
   PubMed Web of Science ®Google Scholar
• Chilton F H, Ellis J M, Olson S C. Wykle RL. 1–0-alkyl-2-arachidonoyl-sn-glycero-3 phosphocholine. A common source of platelet activating factor and arachidonate in human polymorphonudear leukocytes. J Biol Chem 1984; 259: 12014–12019
   PubMed Web of Science ®Google Scholar
• McIntyre T M, Reinhold S L, Prescott S M, Zimmerman G A. Protein kinase C activity appears to be required for the synthesis of platelet activating factor and leukotriene B4 by human neutrophils. J Biol Chem 1987; 262: 15370–15376
   PubMed Web of Science ®Google Scholar
• Billah M M, Bryant R W, Siegel M I. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet activating factor by human neutrophils via phospholipase A2. J Biol Chem 1985; 260: 6899–6906
   PubMed Web of Science ®Google Scholar
• Lin A H, Morton D R, Gorman R R. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes. J Clin invest 1982; 70: 1058–1065
   PubMed Web of Science ®Google Scholar
• Huseh W, Gonzalez-Crussi F, Arroyave J L. Platelet-activating factor induced ischemic bowel necrosis: An investigation of secondary mediators in its pathogenesis. Am J Pathol 1986; 122: 231–239
   PubMed Web of Science ®Google Scholar
• Hsueh W, Gonzales-Crussi F, Arroyave J L. Release of leukotriene C4 by isolated perfused rat small intestine in response to platelet activating factor. J Clin Invest 1986; 78: 108–114
   PubMed Web of Science ®Google Scholar
• Wallace J L, MacNaughton W K, Guarner F, Rodriguez R, Malagelada J R. Role of leukotrienes as mediators of gastric damage and hemoconcentration induced by platelet activating factor. Gas-troenterology 1988; 94: A485
   Web of Science ®Google Scholar
• Whittle B JR, Oren-Wolman N, Guth P H. Gastric vasoconstrictor actions of leukotriene C4, PGF2 and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am J Physiol 1985; 248: G580–G586
   Google Scholar
• Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage: Mediatory role of leukotrienes. Dig Dis Sci 1988; 33: 625–632
   PubMed Web of Science ®Google Scholar
• Dahlen S E, Bjork J, Hedqvist P, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887–3891
   PubMed Web of Science ®Google Scholar
• Ford-Hutchinson A W, Bray M A, Doig M W, Shipley M E, Smith M JH. Leukotriene B: A potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264–265
   PubMed Web of Science ®Google Scholar
• Bokoch G M, Reed P W. Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes. J Biol Chem 1981; 256: 5317–5320
   PubMed Web of Science ®Google Scholar
• Peskar B M, Lange K, Hoppe U, Peskar B A. Ethanol stimulates formation of leukofriene C4 in rat gastric mucosa. Prostaglandins 1986; 31: 283–292
   PubMed Web of Science ®Google Scholar
• Boughton-Smith N K, Whittle B JR. Prostaglandin inhibition of ethanol induced release of gastric mucosai leukotrienes. Gastroenterology 1987; 92: 1325
   Web of Science ®Google Scholar
• Dreyling K W, Hoppe U, Peskar B A, Morgenroth K, Kozuschek W, Peskar B M. Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta 1986; 878: 184–193
   PubMed Web of Science ®Google Scholar
• Martin A, Sturniolo G C, Giacomin D, Fochesato M, Arslan P, Naccarato R. Leukotriene B4 in gastric and duodenal disease. Gastroenterology 1988; 94: A284
   PubMed Web of Science ®Google Scholar
• Tence M, Polonsky J, Le Couedic J P, Benveniste J. Release purification and characterization of platelet activating factor (PAF). Biochimie 1980; 62: 251–259
   PubMed Web of Science ®Google Scholar
• Sharon P, Cohen F, Zifroni A, Karmeli F, Ligumsky M, Rachmilewitz D. Prostanoid synthesis by cultured gastric and duodenal mucosa: possible role in the pathogenesis of duodenal ulcer. Scand J Gastroenterol 1983; 18: 1045–1049
   PubMed Web of Science ®Google Scholar
• Rees W DW, Shorrock C J. ‘Aggressive’ and ‘protective’ factor in the pathogen of peptic ulcer disease. Prostaglandins and leukotrienes in gastrointestinal diseases, W Domschke, H G Dammann, B M Peskar, K H Holtermueller. Springer-Verlag, Berlin 1988; 59–64
   Google Scholar
• Whittle B JR, Kauffman G L, Wallace J L. PAF-induced gastric damage and vascular changes in the cat and dog. Gastroenterology 1987; 92: 1693
   Google Scholar
• Whittle B JR, Morishita T, Ohya Y, Leung F W, Guth P H. Microvascular actions of platelet activating factor on rat gastric mucosa and submucosa. Am J Physiol 1986; 251: G772–G778
   Google Scholar
• Bjork J, Lindbom L, Gerdin B, Smedegard G, Arfors K E, Benveniste J. PAF increases micro-vascular permeability and affects endothelium-granulocyte interaction in microvascular beds. Acta Physiol Scand 1983; 119: 305–308
   PubMedGoogle Scholar
• Doebber T W, Wu M S, Shen T Y. Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. Biochem Biophys Res Commun 1984; 125: 980–987
   PubMed Web of Science ®Google Scholar
• McManus L M, Hanahan D J, Demopoulos C A, Pinckard R N. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphoryline (AGEPC), a synthetic platelet activating factor (PAF), in the rabbit. J Immunol 1980; 124: 2919–2924
   PubMed Web of Science ®Google Scholar
• Poitevin B, Mercia-Huerta J M, Roubin R, Benveniste J. Role of PAF acether (platelet-activating factor) in neutrophil activation. The pulmonary circulation and acute lung injury, S I Said. Futura Publishing, Mount Kisco, NY 1985; 357–373
   Google Scholar
• Hsueh W, Gonzalez-Crussi F, Arroyave J L. Sequential release of leukotrienes and norepineph-rine in rat bowel after platelet-activating factor: a mechanistic study of platelet activating factor-induced bowel necrosis. Gastroenterology 1988; 94: 1412–1418
   PubMed Web of Science ®Google Scholar
• Dreyling K W, Lange K, Peskar B A, Peskar B M. Release of leukotrienes by rat and human gastric mucosa and its pharmacological modification. Br J Pharmacol 1986; 88: 236P
   Google Scholar
• Dembinska-Kiec A, Simmet T, Peskar B A. Release of vasoconstrictor effect of leukotriene C4 like immunoreactive material in the guinea pig mesenteric vascular bed. Eur J Pharmacol 1984; 101: 259–262
   PubMed Web of Science ®Google Scholar
• MacClashan D W, Schleimer R P, Jr, Peters S P, et al. Generation of leukotrienes by purified human lung mast cells. J Clin invest 1982; 70: 747–751
   PubMed Web of Science ®Google Scholar
• Razin E, Mercia-Huerta J M, Lewis R A, Corey E J, Austen K F. Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc Natl Acad Sci USA 1982; 79: 4665–4667
   PubMed Web of Science ®Google Scholar
• Weller P F, Lee C W, Foster D W, Corey E J, Austen K F, Lewis R A. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983; 80: 6726–7630
   Web of Science ®Google Scholar
• Rouzer C A, Scott W H, Cohn Z A, Manning J M. Mouse peritoneal macrophages release leukotriene C4 in response to phagocytic stimulus. Proc Natl Acad USA 1980; 77: 4928–4932
   PubMed Web of Science ®Google Scholar
• Gugler R, Rhoner H G, Kratochvil P, Brandstatter G, Schmitz H. Effect of smoking on duodenal ulcer healing with cimetidine and oxmethidine. Gut 1982; 23: 866–871
   PubMed Web of Science ®Google Scholar
• Peskar B M, Lange K. Role of leukotriene C4 in gastric protection by sulfhydryl modulating agents and metals in the rat. Gastroenterology 1987; 92: 1573
   Web of Science ®Google Scholar